EC 1.1.1.189 (prostaglandin-E2 9-reductase) inhibitor

Term ID

CHEBI:77119

Synonyms

(5Z,13E)-(15S)-9alpha,11alpha,15-trihydroxyprosta-5,13-dienoate:NADP(+) 9-oxidoreductase inhibitor
(5Z,13E)-(15S)-9alpha,11alpha,15-trihydroxyprosta-5,13-dienoate:NADP(+) 9-oxidoreductase inhibitors
9-keto-prostaglandin E2 reductase inhibitor
9-keto-prostaglandin E2 reductase inhibitors
9-ketoprostaglandin reductase inhibitor
9-ketoprostaglandin reductase inhibitors
EC 1.1.1.189 (prostaglandin-E2 9-reductase) inhibitors
EC 1.1.1.189 inhibitor
EC 1.1.1.189 inhibitors
PGE-9-ketoreductase inhibitor
PGE-9-ketoreductase inhibitors
PGE2 9-oxoreductase inhibitor
PGE2 9-oxoreductase inhibitors
PGE2-9-ketoreductase inhibitor
PGE2-9-ketoreductase inhibitors
PGE2-9-OR inhibitor
PGE2-9-OR inhibitors
prostaglandin 9-ketoreductase inhibitor
prostaglandin 9-ketoreductase inhibitors
prostaglandin E 9-ketoreductase inhibitor
prostaglandin E 9-ketoreductase inhibitors
prostaglandin E2-9-oxoreductase inhibitor
prostaglandin E2-9-oxoreductase inhibitors
prostaglandin-E2 9-reductase (EC 1.1.1.189) inhibitor
prostaglandin-E2 9-reductase (EC 1.1.1.189) inhibitors
reductase, 15-hydroxy-9-oxoprostaglandin inhibitor
reductase, 15-hydroxy-9-oxoprostaglandin inhibitors

(all 27)

Definition

An EC 1.1.1.* (oxidoreductase acting on donor CH-OH group, NAD(+) or NADP(+) acceptor) inhibitor that interferes with the action of prostaglandin-E2 9-reductase (EC 1.1.1.189).

References

Wikipedia:Prostaglandin-E2_9-reductase

Ontology

ChEBI ( EBI )

Relationships

is a type of: EC 1.1.1.* (oxidoreductase acting on donor CH-OH group, NAD(+) or NADP(+) acceptor) inhibitor

EC 1.1.1.* (oxidoreductase acting on donor CH-OH group, NAD(+) or NADP(+) acceptor) inhibitor Show first 5 Terms
inverse has_role: hexadecanoic acid

hexadecanoic acid Show first 5 Terms

Phenotype

Phenotype resulting from EC 1.1.1.189 (prostaglandin-E2 9-reductase) inhibitor

Phenotype where environments contain EC 1.1.1.189 (prostaglandin-E2 9-reductase) inhibitor

Phenotype modified by environments containing EC 1.1.1.189 (prostaglandin-E2 9-reductase) inhibitor

Phenotype affecting EC 1.1.1.189 (prostaglandin-E2 9-reductase) inhibitor

Human Disease Model